MOSCOW. March 31 (Interfax) - The Russian government is launching new programs for developing agricultural machinery and producing veterinary pharmaceuticals.

France's Ceva Animal Health has raised 5.5 billion euros ($5.95 billion) in equity, boosting its valuation to 9.2 billion euros, as shareholders including the billionaire Bettencourt-Meyers family ...

This Amendment expands the scope of Northstrive Biosciences’ license rights to all uses in animal health ... to entry within the animal health pharmaceutical sector. Northstrive Biosciences ...

Telomir Pharmaceuticals (NASDAQ:TELO) announced on Wednesday, preclinical findings demonstrating that Telomir-1 reduces tumor size by approximately 50% in a prostate cancer animal model using highly ...

This groundbreaking finding suggests that Telomir-1 may selectively benefit healthy cells while suppressing malignant growth, challenging the assumption that telomere-elongating drugs inherently ...

"These results not only confirm in-vitro observations in aggressive, androgen-independent human prostate cancer cells but also represent a game-changing discovery in animal models. We are seeing a ...